share_log

Aadi Bioscience Analyst Ratings

Benzinga ·  Nov 14, 2023 10:11
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/13/2023 689.47% HC Wainwright & Co. $45 → $36 Maintains Buy
08/10/2023 886.84% HC Wainwright & Co. → $45 Reiterates Buy → Buy
06/08/2023 886.84% HC Wainwright & Co. → $45 Reiterates Buy → Buy
05/17/2023 886.84% HC Wainwright & Co. → $45 Reiterates Buy → Buy
03/29/2023 886.84% HC Wainwright & Co. $48 → $45 Maintains Buy
04/11/2022 952.63% HC Wainwright & Co. $49 → $48 Maintains Buy
01/11/2022 886.84% Jefferies → $45 Initiates Coverage On → Buy
11/24/2021 974.56% HC Wainwright & Co. $47 → $49 Maintains Buy
10/01/2021 Cowen & Co. Initiates Coverage On → Outperform
09/14/2021 1018.42% Ladenburg Thalmann → $51 Initiates Coverage On → Buy
09/08/2021 886.84% Piper Sandler → $45 Initiates Coverage On → Overweight
08/30/2021 930.7% HC Wainwright & Co. $22 → $47 Maintains Buy

What is the target price for Aadi Bioscience (AADI)?

The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $36.00 expecting AADI to rise to within 12 months (a possible 689.47% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Aadi Bioscience (AADI)?

The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by HC Wainwright & Co., and Aadi Bioscience maintained their buy rating.

When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Is the Analyst Rating Aadi Bioscience (AADI) correct?

While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a maintained with a price target of $45.00 to $36.00. The current price Aadi Bioscience (AADI) is trading at is $4.56, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment